Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: The ZIKAlliance consortium


Por: Avelino-Silva V.I., Mayaud P., Gotuzzo E., Martínez P.A., Saba Villarroel P.M., Jaenisch T., Rosenberger K.D., Morales I., Tobian F., Uhlmann L., Pohl M., Schretzmann J., Leege A., Marques E.T.A., Viana I.F.T., Lins R.D., Brasil P., De Filippis A.M.B., Duarte A.C.M., De Melo Espíndola O., Bonaldo M., Rabello R., Damasceno L., Avelino-Silva V., Segurado A., Sabino E., Mendes-Correa M.C., Nacul L., Alexander N., Netto E.M., Tami A., Bethencourt S., Falcon C., Rodríguez E., Matos V., Tinedo M.J., La Rosa Y., Murillo M., Villar L.A., Miranda M.C., Lozano A., Herrera V.M., Gomez A., Gelvez R.M., Ortiz R., Soria C., Dimitrakis L., Salgado S.P., Arrata M.R., Allison H.G., Talledo M., Villarroel P.M.S., Torres E.M., Guzmán M.G., Martínez Rodríguez P.A., Vera M.A., Santana B.G., Reyes A., Álvarez S.S., Dorticós D.F., Hegewisch-Taylor J., Alpuche-Aranda C., López-Gatell H., González-Diaz E., Pavía-Ruz N., Borja-Aburto V.H., Gonzalez C., Grajales C., Rojas T., Arriaga L., Vallejos A., Hoen B., Tynevez D., De Lamballerie X., Thirion L., Drexler J.F., Rockx B., Van Gorp E., Koopmans M.

Publicada: 1 ene 2019
Categoría: Infectious diseases

Resumen:
Background: The European Commission (EC) Horizon 2020 (H2020)-funded ZIKAlliance Consortium designed a multicentre study including pregnant women (PW), children (CH) and natural history (NH) cohorts. Clinical sites were selected over a wide geographic range within Latin America and the Caribbean, taking into account the dynamic course of the ZIKV epidemic. Methods: Recruitment to the PW cohort will take place in antenatal care clinics. PW will be enrolled regardless of symptoms and followed over the course of pregnancy, approximately every 4 weeks. PW will be revisited at delivery (or after miscarriage/abortion) to assess birth outcomes, including microcephaly and other congenital abnormalities according to the evolving definition of congenital Zika syndrome (CZS). After birth, children will be followed for 2 years in the CH cohort. Follow-up visits are scheduled at ages 1-3, 4-6, 12, and 24 months to assess neurocognitive and developmental milestones. In addition, a NH cohort for the characterization of symptomatic rash/fever illness was designed, including follow-up to capture persisting health problems. Blood, urine, and other biological materials will be collected, and tested for ZIKV and other relevant arboviral diseases (dengue, chikungunya, yellow fever) using RT-PCR or serological methods. A virtual, decentralized biobank will be created. Reciprocal clinical monitoring has been established between partner sites. Substudies of ZIKV seroprevalence, transmission clustering, disabilities and health economics, viral kinetics, the potential role of antibody enhancement, and co-infections will be linked to the cohort studies. Discussion: Results of these large cohort studies will provide better risk estimates for birth defects and other developmental abnormalities associated with ZIKV infection including possible co-factors for the variability of risk estimates between other countries and regions. Additional outcomes include incidence and transmission estimates of ZIKV during and after pregnancy, characterization of short and long-term clinical course following infection and viral kinetics of ZIKV. Study registrations: clinicaltrials.gov NCT03188731 (PW cohort), June 15, 2017; clinicaltrials.gov NCT03393286 (CH cohort), January 8, 2018; clinicaltrials.gov NCT03204409 (NH cohort), July 2, 2017. © 2019 The Author(s).

Filiaciones:
Department of Infectious and Parasitic Diseases, Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
Hospital Sirio-Libanês, São Paulo, Brazil
London School of Hygiene and Tropical Medicine, London, United Kingdom
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
Facultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela
Universidad Industrial de Santander, Bucaramanga, Colombia
Department of Infectious Diseases, Section Clinical Tropical Medicine, Heidelberg University Hospital, INF 324, Heidelberg, 69120, Germany
German Centre for Infection Research (DZIF), Heidelberg Site, Cologne, Germany
Institute of Medical Biometry and Informatic, Heidelberg University Hospital, Heidelberg, Germany
Aggeu Magalhães Institute, Oswaldo Cruz Foundation (FIOCRUZ), Recife, Brazil
Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil
Universidad Católica Santiago de Guayaquil, Guayaquil, Ecuador
SOSECALI C., Ltda, Guayaquil, Ecuador
Instituto Nacional de Investigacion en Salud Publica Dr. Leopoldo Izquieta Perez, Guayaquil, Ecuador
Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
Pedro Kouri Tropical Medicine Institute (IPK), Havana, Cuba
Centro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Mexico
Mexican Institute of Social Security, Mexico City, Mexico
Federal University of Bahia, Salvador, Brazil
Centro Nacional de Enfermedades Tropicales (CENETROP), De La Sierra, Santa Cruz, Bolivia
INSERM Centre d'Investigation Clinique 1424, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
Service de Maladies Infectieuses et Tropicales, Dermatologie, Médecine Interne, Centre Hospitalier, Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
Université des Antilles et de la Guyane, Faculté de Médecine Hyacinthe Bastaraud, Pointe-à-Pitre, EA, 4537, France
University of Pittsburgh, Center for Vaccine Research, Pittsburgh, PA, United States
Department of Viroscience, WHO CC Arbovirus and Hemorrhagic Fever Viruses Reference and Research, Erasmus MC, Rotterdam, Netherlands
Aix-Marseille University, Marseille, France
ISSN: 14712334
Editorial
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 19 Número: 1
Páginas:
WOS Id: 000511160500003
ID de PubMed: 31878895

MÉTRICAS